To be a successful applicant, you need to either have a BMI of 27 kg/m2 or higher while also having a weight-related condition or have a BMI of 30 kg/m2 or higher
In addition, there may be a limited number of market makers and/or liquidity providers in the marketplace
Key takeaways: Glucagon-like peptide-1 (GLP-1) injections such as Wegovy (semaglutide) and Zepbound (tirzepatide) are the most effective weight-loss medications available today
Responses to medications can differ greatly based on factors such as metabolic characteristics, tolerability, lifestyle, and personal preferences
The next generation of regimens may involve combining GLP-1 or dual GIP/GLP-1 receptor agonists with other nutrient-based hormone receptor agonists or antagonists that offer equal or greater effectiveness with fewer gastrointestinal adverse effects
Our network has helped patients document their injuries and pursue compensation for ongoing medical care